The COVID-19 Vaccine Moderna is not currently approved for use in the Philippines, and the Company will work with regulators to pursue necessary approvals prior to distribution. �We appreciate the continued confidence demonstrated by the government of the Philippines through this new agreement, as well as the support of the private sector, resulting in 20 million doses secured for the country,� said St�phane Bancel, Chief Executive Officer of Moderna. �This agreement supports the ongoing efforts in the Philippines to secure access to a safe and effective COVID-19 vaccine and reflects Moderna�s continued commitment to expanding access to its vaccine around the world.� The initial procurement by the Philippines of 13 million doses was announced on March 6, 2021. Under the terms of this agreement, deliveries would begin in mid-2021. About the COVID-19 Vaccine Moderna The COVID-19 Vaccine Moderna (referred to in the U.S. as the Moderna COVID-19 Vaccine) is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein, which was co-developed by Moderna and investigators from NIAID�s Vaccine Research Center.